Economic considerations in the use of the platelet GP IIb/IIIa inhibitor abciximab in percutaneous coronary intervention

European Heart Journal, Supplement

Volumn 1, Issue E, 1999, Pages

  Hermiller, J ^a   Kereiakes, D J ^a  

^a ST VINCENT HOSPITAL   (United States)

Author keywords

Abciximab; Cost effectiveness of treatment; Glycoprotein IIb IIIa receptor blockade

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032966222     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)